Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy

Yicun Wang,Jiyao Sheng,Jin Chai,Cuilin Zhu,Xin Li,Wei Yang,Ranji Cui,Tongtong Ge
DOI: https://doi.org/10.3389/fimmu.2021.729336
IF: 7.3
2021-09-10
Frontiers in Immunology
Abstract:Glioma is a life-threatening malignant tumor. Resistance to traditional treatments and tumor recurrence present major challenges in treating and managing this disease, consequently, new therapeutic strategies must be developed. Crossing the blood-brain barrier (BBB) is another challenge for most drug vectors and therapy medications. Filamentous bacteriophage can enter the brain across the BBB. Compared to traditional drug vectors, phage-based drugs offer thermodynamic stability, biocompatibility, homogeneity, high carrying capacity, self-assembly, scalability, and low toxicity. Tumor-targeting peptides from phage library and phages displaying targeting peptides are ideal drug delivery agents. This review summarized recent studies on phage-based glioma therapy and shed light on the developing therapeutics phage in the personalized treatment of glioma.
immunology
What problem does this paper attempt to address?